Oticon Medical has a new Web site that includes information on its bone anchored treatment process, the latest improvements, and multimedia information geared toward professionals as well as patients.
Read More
Good Vibrations Day is an inclusive, non-branded campaign aimed at educating the public about bone conduction as a hearing treatment.
Read More
George Cire, Chris James, and Paula Greenham review the major treatment modalities, the general indications for implant use and referral, and present a picture of current clinical practice as reflected in Cochlear Ltd’s Implant Recipient Observational Study (IROS).
Read More
Cochlear Limited (ASX: COH) announced the Food and Drug Administration (FDA)’s clearance of the new Cochlea Baha 6 Max Sound Processor, designed to “improve hearing outcomes for people with SSD (single-sided deafness), conductive or mixed hearing loss.”
Read More
The research and support in practice by trained hearing health professionals provided the foundation to approve the indication be lowered to 9 months, along with the considerable developments in technology and evolving speech coding strategies in modern day cochlear implant devices.
Read More
Cochlear Limited (ASX: COH), an implantable hearing solutions company, announced the US Food and...
Read More
CROS and BiCROS hearing aids are not the only treatment options for those with unilateral hearing loss. This article reviews other options and potential future avenues for unilateral sensorineural hearing loss and single-sided deafness, as well as for unilateral conductive hearing loss.
Read More
Douglas Beck & Virginia Ramachandran examine the various forms of unilateral hearing loss and review the various treatment methods with particular emphasis on the effectiveness of CROS and BiCROS hearing aid fittings.
Read More
Ponto 4 will officially launch in the US in early summer 2019.
Read More
The Baha SoundArc was designed to provide children with conductive hearing loss, mixed hearing loss, or single-sided sensorineural deafness (SSD) with the hearing performance and amplification they need to facilitate language development on par with their hearing peers.
Read More
Oticon Medical has obtained 510(k) clearance from the FDA to market the powerful new Ponto 3 bone-anchored, abutment-level sound processor, which has a fitting range down to 65 dB HL (BC).
Read More
Doug Beck, AuD, interviews Dr David M. Baguley, head of Audiology/Hearing Implants at Cambridge University Hospitals NHS Trust in England, and the author of more than 150 peer-reviewed publications. This interview focuses on Dr Baguley’s newest 2015 book, Tinnitus: Clinical and Research Perspectives, co-edited by Prof Marc Fagelson.
Read More
Oticon Medical announced that its 4th annual Scientific Meeting drew more than 90 professionals representing 23 countries to its headquarters in Copenhagen. The 3-day conference combined scientific presentations, lectures, and roundtable discussions with focused programs concentrating on audiology and surgery.
Read More
Thieme Publishers announced its launch of a new book, Surgery for Cochlear and Other Auditory Implants, which provides an overview of anatomy and other information for cochlear and other auditory implantation. The book is intended to be a comprehensive, high-level surgical reference and atlas tailored for surgeons who are undertaking training for cochlear implant procedures and implantable auditory devices.
Read More
Oticon Medical mourns the passing of Curt Gorman, who was the senior vice president of its BAHS Division. Gorman had been a valued member of the management team since Oticon Medical’s inception in 2009.
Read More